Objectives: The purpose of this study was to determine whether a commercial formulation of hypochlorous acid hygiene solution (0.01%), Avenova, can destroy existing biofilms formed by ocular clinical bacterial isolates, including blepharitis isolates of Staphylococcus aureus and coagulase-negative staphylococci, and a keratitis isolate of Pseudomonas aeruginosa. Methods: Biofilms grown in bacterial growth media on disposable contact lens cases were challenged with hypochlorous acid hygiene solution. At various time points, surviving bacteria were quantified by serial dilution and colony counts. Staphylococcus aureus biofilms formed on glass were challenged using a hypochlorous acid hygiene solution and imaged using vital staining and confocal laser scanning microscopy. Results: Bactericidal activity ($3 Log 10 ; 99.9%) was observed for all tested bacterial species after a 30-min exposure. Staphylococcus aureus biofilms had a bactericidal level of killing by 10 min (P,0.01), Staphylococcus capitis by 5 min (P,0.001), Staphylococcus epidermidis by 30 min (P,0.001), and P. aeruginosa by 10 min (P,0.01). Confocal microscopy and crystal violet staining analysis of bacterial biofilms treated with hypochlorous acid solution both demonstrated that biofilm bacteria were readily killed, but biofilm structure was largely maintained. Conclusions: Hypochlorous acid (0.01%) hygiene solution was able to achieve bactericidal levels of killing of bacteria in biofilms but did not disrupt biofilm structures. Susceptibility of tested staphylococcal blepharitis isolates varied by species, with S. capitis being the most susceptible and S. epidermidis being the least susceptible.
B lepharitis, or inflammation of the eyelids, is a chronic ocular surface disease. 1, 2 Patients present with significant discomfort and symptoms that include redness, itching, burning, foreign body sensations, and blurred vision. 2 Blepharitis is quite common 1, 2 ; one study estimated that 37% to 47% of patients seen by ophthalmologists and optometrists have blepharitis. 1 Although bacteria may or may not initiate blepharitis, the oily and inflamed eyelid margins of patients with blepharitis are frequently colonized by bacteria, predominantly by Grampositive bacteria including species of the Staphylococcus, Propronibacterium, and Corynebacterium genera. [3] [4] [5] A bioinformatic study that used 16S rRNA analysis on eyelash and tear samples from blepharitis versus normal patients (n¼7 and 4, respectively) came to a largely consistent conclusion and recorded a relative increase in bacteria from the Staphylococcus and Corynebacterium genera from the eyelids and tears of patients with blepharitis. 6 Another recent study of 36 patients used MALDI-TOF and 16S rRNA analysis to identify bacteria from the eyelid skin of patients with blepharitis 7 ; 14 genera of bacteria were isolated with Staphylococcus species being the most prevalent.
It is hypothesized that lid colonization leads to local inflammation. 8, 9 Chronic recurrent inflammation and antibiotic tolerance are hallmarks of biofilm-associated infections. Because of this and the increased bacterial burdens of lids and lashes of patients with blepharitis, it has been hypothesized that infectious blepharitis is a biofilmassociated disease. 10, 11 Current treatment routines include cleaning the eyelids, the use of warm compresses, and often the use of topical antibiotics. 2 However, many individuals with blepharitis require long-term therapy, as blepharitis is chronic and relief of symptoms may be temporary. A new therapeutic approach for the treatment of blepharitis is the use of stabilized hypochlorous acid (HOCl). Avenova, an FDA-cleared device previously known as I-Lid Cleanser, has a proprietary pure formulation of 0.01% HOCl as the active ingredient. 7 In nature, HOCl is formed by polymorphonuclear neutrophils to kill microorganisms, 12 and commercial formulations have been shown to be useful in treatment of nonhealing wounds that are also associated with chronic infection by staphylococci and other microbes. 13 Previous studies indicate that HOCl can kill bacteria in biofilms [14] [15] [16] [17] ; however, clinical blepharitis isolates were not tested. The goal of this study was to test whether a clinical formulation of HOCl is effective in killing bacteria in biofilms formed by ocular clinical isolates.
MATERIALS AND METHODS
Bacterial Culture, Biofilm Formation, and Susceptibility Analysis Bacterial isolates were confirmed clinical samples obtained at the Charles T. Campbell Ophthalmic Microbiology Laboratory at the UPMC Eye Center. Bacterial strains were from patients with blepharitis 18 or keratitis. 19 Bacteria were maintained in frozen glycerol stocks at 280°C, streaked out onto blood agar plates (tryptic-soy agar with 5% sheep erythrocytes; Remel, Lenexa, KS). Bacterial single colonies were used to inoculate 5 mL cultures of brain heart infusion (BHI) broth for staphylococci or lysogeny broth (LB) for Pseudomonas aeruginosa. Bacteria were diluted in BHI+glu-cose (0.2% vol/vol) for staphylococci or LB for P. aeruginosa to an OD 600 ¼0.01. Bacteria (0.4 mL) were introduced into contact lens cases and incubated at 37°C for 24 hrs. Contact lens cases were Deepwell lens cases obtained from Beitler McKee Optical Company, Pittsburgh, PA. Nonbiofilm bacteria were removed by aspiration, and the remaining biofilms were washed twice with 0.5 mL of phosphate-buffered saline (PBS, pH 8). Biofilms were challenged with 0.5 mL of Avenova or azithromycin (1%) submerging the biofilms for 1, 5, 10, or 30 min. Biofilms were washed with 0.5 mL of PBS to remove HOCl or azithromycin, and colony forming units (CFUs) were determined by serial dilution. Avenova ophthalmic hygiene solution was provided by NovaBay Pharmaceuticals, Inc. Emeryville CA. Avenova consists of HOCl-preserved (0.01%) saline solution, referred to here as HOCl solution. As a negative control, biofilms were incubated with 0.5 mL PBS for 30 min. Bacteria were removed from the contact lens cases using Dacron swabs, and CFUs were determined by colony counts on LB agar plates. Experiments were performed with five or more independent replicates for each time point and isolate on three or more separate occasions. Colony forming units were enumerated and Log 10 transformed; the absence of bacteria was recorded at the limit of detection rather than zero, as noted in the figure legend. Experiments were performed on several different days, and the mean values of the CFU were compared using one-way analysis of variance with Tukey's posttest.
Alternatively, biofilms were stained and fixed with crystal violet (0.1% vol/vol) for 10 min, air dried, and imaged by using a digital scanner, or evaluated by confocal laser scanning microscopy (noted below).
Microscopy
Staphylococcus aureus B1412 biofilms were formed on glassbottomed MatTek plates in BHI+glucose medium as described above. Planktonic bacteria were removed by washing biofilms twice with PBS and biofilms were challenged with HOCl solution or PBS as a nontoxic control for 30 min and washed twice with PBS. Biofilms were stained with LIVE/DEAD BacLight bacterial viability kit (ThermoFisher, Pittsburgh, PA) after the manufacturer's recommended concentrations for 30 min. Biofilms were imaged with a 60X oil immersion objective using an Olympus IX-81-inverted microscope with an FV-1000 laser scanning confocal system (Olympus) and FluoView imaging software. Experiments were performed twice (n¼4 per group).
RESULTS

Impact of HOCl Solution on Biofilms Formed by Blepharitis Isolates of Staphylococcus aureus and Coagulase-Negative Staphylococci
Blepharitis is associated with colonization of eyelashes and eyelids by bacteria of the Staphylococcus genus. 2 Biofilms were formed on contact lens cases for 24 hr and then challenged with biofilms were highly susceptible to HOCl solution with a bactericidal ($3-Log 10 killing) effect observed as early as 5 min (Fig. 1A) . Staphylococcus epidermidis strain B1483 biofilms were less susceptible to HOCl solution but were still significantly reduced by over 3 Log 10 units at 30 min (Fig. 1A) . Staphylococcus epidermidis strain B1472 also showed limited susceptibility with a significant (P,0.05) 1.2 Log 10 reduction in viable CFU detected by 30 min (Fig. 1A) .
We then tested whether a shorter HOCl challenge could reduce the viability of bacteria in biofilms using, Staphylococcus capitis B1379. A significant 1.5 Log 10 reduction in biofilm CFU (P,0.0001, Student's t test) was measured from S. capitis biofilms treated with HOCl compared with the PBS control after a 60-s exposure ( Fig. 2A) .
Staphylococcus aureus strain B1412 biofilms were significantly reduced by HOCl solution by as early as 5 min of exposure, with a bactericidal effect measured at 30 min (Fig. 1B) . Confocal laser scanning microscopy was used to image HOCl solution and PBS-treated S. aureus B1412 biofilms (Fig. 3) . Live-dead staining of the biofilm supports the CFU analysis, with the HOCl solution-treated cells strongly taking up propidium iodide, whereas the PBS-treated control biofilms remained viable with minimal propidium iodide staining (Fig.  3) . The same strain was similarly tested with azithromycin (1%) because macrolides are commonly used to treat blepharitis. B1412 was previously characterized as susceptible to azithromycin with a minimum inhibitory concentration (MIC) of 1 mg/mL. 18 Although azithromycin is effective against strain B1412 in a planktonic state, 18 it was unable to effectively kill S. aureus B1412 biofilm bacteria in vitro, with less than a 0.5 Log 10 reduction measured after 30 min of exposure (Fig. 1B) .
Crystal violet staining of biofilms can be used to measure biofilm biomass. Crystal violet staining of strain B1412 biofilms reveals that although the bacteria within the biofilm are killed, 30 min of HOCl solution did not disrupt gross biofilm structure (Fig. 4) . Similar results were observed with tested coagulasenegative staphylococcal strains (Fig. 4) .
Impact of HOCl Solution on Biofilms Formed by a Keratitis Isolate of Pseudomonas aeruginosa
Although P. aeruginosa is frequently associated with contact lens-associated keratitis, it can infrequently cause blepharitis and blepharoconjunctivitis. 20, 21 Moreover, P. aeruginosa biofilms are well known to be highly resistant to antimicrobial therapy. 22 Pseudomonas aeruginosa keratitis isolate K900 biofilms were challenged by HOCl solution in vitro and were found to be highly susceptible to HOCl solution killing, with a 4 Log 10 CFU reduction after 5 min of treatment, and the elimination of any detectable viable cells by 30 min (Fig. 1C) . Pseudomonas aeruginosa K900 biofilms treated with HOCl were reduced 2.8 Log 10 compared with biofilms treated with the PBS control after a 60-s exposure (P,0.0001, Student's t test) (Fig. 2B) . Like what was observed with tested staphylococci, P. aeruginosa K900 biofilms were not structurally destroyed by HOCl solution (Fig. 4) .
DISCUSSION
This study demonstrates that bacteria within biofilms formed by blepharitis isolates of the Staphylococcus genus are killed by HOCl solution. The effect varied by species, with S. capitis and S. aureus being more susceptible than S. epidermidis. As S. epidermidis is part of the healthy skin flora and S. aureus is a more pathogenic species that transiently colonizes humans, the ability of HOCl solution to selectively kill S. aureus while maintaining S. epidermidis may be beneficial. Pseudomonas aeruginosa keratitis isolate K900 biofilm bacteria were particularly susceptible HOCl solution, with a 2.8 Log 10 reduction of biofilm CFU with a 60-s exposure.
Bacterial biofilms are notoriously recalcitrant to antimicrobial therapy and this is due to differential expression of genes in biofilms, different microenvironments within biofilms that reduce the activity of antibiotics, the presence of persister cells, and a large number of nondividing bacteria in a low metabolic state. 10, 22, 23 This phenomenon of biofilm antimicrobial tolerance was exemplified in this study where the S. aureus strain B1412 that is susceptible to azithromycin (MIC of 1 mg/mL for planktonic cells) 18 was almost completely resistant to azithromycin at 10,000 mg/mL when in a biofilm. This may not be particularly surprising as azithromycin is bacteriostatic for susceptible S. aureus and 30 min is not a long time for an antibiotic to work, but the differences between biofilm susceptibility to an anti-infective such as HOCl and an antibiotic were clearly demonstrated in Figure 1B .
In this study, contact lens cases were used. Although the primary focus was as a proof of principle test as to whether biofilms formed by blepharitis isolates on a given surface are susceptible to HOCl, data suggest that there is a potential application to kill bacteria on contact lenses using this disinfectant, where a 30 min or longer application is recommended. This study demonstrates that bacteria in biofilms were killed by HOCl solution; however, bacterial biofilms formed by blepharitis isolates remained structurally intact as demonstrated by confocal microscopy and crystal violet staining.
FIG. 4.
HOCl acid hygiene solution does not disrupt biofilms formed by clinical ocular isolates. Crystal violet stained biofilms were similar with and without HOCl treatment for up to 30 min (309); PBS served as a negative control. Representative biofilms from the blepharitis isolates and one P. aeruginosa keratitis isolate (K900) on the contact lens cases used in this study. SA, S. aureus; SC, S. capitus; SE, S. epidermidis; PA, P. aeruginosa; PBS, phosphate-buffered saline.
